Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

460 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Diagnosis and therapy of testicular tumors].
Albers P. Albers P. Urologe A. 2002 Jul;41(4):374-85; quiz 386-7. doi: 10.1007/s00120-002-0219-x. Urologe A. 2002. PMID: 12214458 German. No abstract available.
Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.
Perabo FG, Kamp S, Schmidt D, Lindner H, Steiner G, Mattes RH, Wirger A, Pegelow K, Albers P, Kohn EC, von Ruecker A, Mueller SC. Perabo FG, et al. Br J Cancer. 2001 May 18;84(10):1330-8. doi: 10.1054/bjoc.2001.1808. Br J Cancer. 2001. PMID: 11355943 Free PMC article.
Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas.
Rothe M, Ko Y, Albers P, Wernert N. Rothe M, et al. Am J Pathol. 2000 Nov;157(5):1597-604. doi: 10.1016/S0002-9440(10)64797-9. Am J Pathol. 2000. PMID: 11073819 Free PMC article.
Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer.
Brennemann W, Stoffel-Wagner B, Wichers M, Helmers A, Albers P, Mezger J, Klingmüller D. Brennemann W, et al. J Urol. 1998 Jun;159(6):1942-6. doi: 10.1016/s0022-5347(01)63203-8. J Urol. 1998. PMID: 9598493 Clinical Trial.
Six months after irradiation a significant increase in FSH (p <0.01) associated with a decrease in sperm density was observed in both groups and 24 months after radiotherapy patients with initially normal FSH had significantly lower serum FSH (p <0.01) associa …
Six months after irradiation a significant increase in FSH (p <0.01) associated with a decrease in sperm density was observed in b …
Human and mouse RAD17 genes: identification, localization, genomic structure and histological expression pattern in normal testis and seminoma.
von Deimling F, Scharf JM, Liehr T, Rothe M, Kelter AR, Albers P, Dietrich WF, Kunkel LM, Wernert N, Wirth B. von Deimling F, et al. Hum Genet. 1999 Jul-Aug;105(1-2):17-27. doi: 10.1007/s004399900067. Hum Genet. 1999. PMID: 10480350
Possible role of FDG-PET in the evaluation of urologic malignancies.
Bender H, Schomburg A, Albers P, Ruhlmann J, Biersack HJ. Bender H, et al. Anticancer Res. 1997 May-Jun;17(3B):1655-60. Anticancer Res. 1997. PMID: 9179213 Review.
Extensive surgery in metastatic testicular cancer.
Melchior D, Müller SC, Albers P. Melchior D, et al. Aktuelle Urol. 2003 Jul;34(4):214-22. doi: 10.1055/s-2003-41600. Aktuelle Urol. 2003. PMID: 14566667 Review.
Organ sparing surgery for malignant germ cell tumor of the testis.
Heidenreich A, Weissbach L, Höltl W, Albers P, Kliesch S, Köhrmann KU, DIeckmann KP; German Testicular Cancer Study Group. Heidenreich A, et al. J Urol. 2001 Dec;166(6):2161-5. doi: 10.1016/s0022-5347(05)65526-7. J Urol. 2001. PMID: 11696727
Erythropoietin in urologic oncology.
Albers P, Heicappell R, Schwaibold H, Wolff J; German Association of Urological Oncology, Subdivision of the German Cancer Society. Albers P, et al. Eur Urol. 2001 Jan;39(1):1-8. doi: 10.1159/000052404. Eur Urol. 2001. PMID: 11173931 Review.
460 results
Jump to page